Condition: Monkeypox · Sponsor: McMaster University
A cluster randomized controlled trial to determine if smallpox vaccine reduces secondary cases and symptom severity in persons exposed to mpox.
This description comes directly from the study's public registry record.
Mark Loeb, MD · 9055259140 · loebm@mcmaster.ca
Always discuss trial participation with your own doctor first.
| Catholic University of Bukavu | Kinshasa, Bukavu, Democratic Republic of the Congo | Recruiting |
| Federal Medical Center | Abuja, Nigeria | Not Yet Recruiting |
| University of Abuja Teaching Hospital | Abuja, Nigeria | Not Yet Recruiting |
| University of Ibadan | Ibadan, Nigeria | Not Yet Recruiting |
| Irrua Specialist Teaching Hospital | Irrua, Nigeria | Not Yet Recruiting |
| Aminu Kano Teaching Hospital | Kano, Nigeria | Not Yet Recruiting |
| Lagos University Teaching Hospital | Lagos, Nigeria | Not Yet Recruiting |
| Niger Delta Teaching Hospital | Okolobiri, Nigeria | Not Yet Recruiting |
| University of Port Harcourt Teaching Hospital | Port Harcourt, Nigeria | Not Yet Recruiting |
| Makerere University Lung Institute | Kampala, Uganda | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05745987